ProCE Banner Activity

STOP Study: Incidence and Predictors of ALT Flares in HBeAg-Negative Patients Discontinuing NA Therapy for CHB

Slideset Download
Conference Coverage
Male sex and high HBV DNA were associated with increased flare risk in this single-center, randomized phase IV study.

Released: April 15, 2019

Expiration: April 13, 2020

No longer available for credit.
Begin Activity

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

AbbVie

Gilead